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Summary
Background—Babies with low birthweight (<2500 g) are at increased risk of early mortality.
However, low birthweight includes babies born preterm and with fetal growth restriction, and not
all these infants have a birthweight less than 2500 g. We estimated the neonatal and infant
mortality associated with these two characteristics in low-income and middle-income countries.
Methods—For this pooled analysis, we searched all available studies and identified 20 cohorts
(providing data for 2 015 019 livebirths) from Asia, Africa, and Latin America that recorded data
for birthweight, gestational age, and vital statistics through 28 days of life. Study dates ranged
from 1982 through to 2010. We calculated relative risks (RR) and risk differences (RD) for
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mortality associated with preterm birth (<32 weeks, 32 weeks to <34 weeks, 34 weeks to <37
weeks), small-for-gestational-age (SGA; babies with birthweight in the lowest third percentile and
between the third and tenth percentile of a US reference population), and preterm and SGA
combinations.
Findings—Pooled overall RRs for preterm were 6·82 (95% CI 3·56–13·07) for neonatal
mortality and 2·50 (1·48–4·22) for post-neonatal mortality. Pooled RRs for babies who were SGA
(with birthweight in the lowest tenth percentile of the reference population) were 1·83 (95% CI
1·34–2·50) for neonatal mortality and 1·90 (1·32–2·73) for post-neonatal mortality. The neonatal
mortality risk of babies who were both preterm and SGA was higher than that of babies with either
characteristic alone (15·42; 9·11–26·12).
Interpretation—Many babies in low-income and middle-income countries are SGA. Preterm
birth affects a smaller number of neonates than does SGA, but is associated with a higher
mortality risk. The mortality risks associated with both characteristics extend beyond the neonatal
period. Differentiation of the burden and risk of babies born preterm and SGA rather than with
low birthweight could guide prevention and management strategies to speed progress towards
Millennium Development Goal 4—the reduction of child mortality.
Funding—Bill & Melinda Gates Foundation.
Introduction
An estimated 20 million infants every year are born with low birthweight (LBW; <2500 g),1
and these infants have an increased risk mortality in the first year of life. The primary causes
of LBW are preterm birth, intrauterine growth restriction (IUGR), or a combination of the
two. Of 135 million children born in low-income and middle-income countries (LMICs) in
2010, an estimated 29·7 million were born both term and small-for-gestationalage (SGA),
10·9 million were born preterm and appropriate-for-gestational-age, and 2·8 million were
born preterm and SGA.2 Risk factors and interventions to reduce the number of babies born
SGA might differ from those to reduce the number of babies born preterm. The survival and
growth patterns of preterm or growth-restricted newborn babies are not well described in
LMICs and the contribution to mortality of non-LBW babies (≥2500 g) who are preterm or
those with IUGR in such settings is unknown.
Few studies in LMICs have investigated differences in mortality by extent of prematurity,
IUGR, or the two in combination,3,4 or mortality risk in infants who are SGA stratified by
gestational age.5-10 Examination of the mortality risk by degree of prematurity and SGA as a
proxy for IUGR might be crucial in understanding the attributable disease burden, especially
because regions such as south Asia have a reported SGA prevalence of about 40%.11,12
Such mortality risk estimates and attributable burden could enable the specific targeting of
these disorders with appropriate interventions to more effectively save lives.
The Child Health Epidemiology Reference Group (CHERG) previously examined the risk of
infant mortality associated with term-LBW as a proxy for IUGR.13 However, term-LBW
excludes growth-restricted infants weighing more than 2500 g and high risk infants born
both preterm and SGA, and such associations between mortality and SGA-non-LBW or
SGA-preterm have not been well described in LMICs. With more population-based studies
in LMICs now collecting data for gestational age in addition to birthweight, the CHERG
identified an opportunity to assess the mortality risk of SGA and preterm on early neonatal,
late neonatal, neonatal, post-neonatal, and infant mortality.
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We searched Medline, WHO regional databases (African Index Medicus, LILAS, EMRO),
bibliographies of sentinel articles and reviews, and grey literature to identify potential
datasets from low-income and middle-income countries that recorded data for gestational
age and birthweight, and systematically recorded vital status from delivery through at least
28 days of life. The most recent search was done on Feb 22, 2010. We applied no no date or
language restrictions. Search terms included “preterm or SGA”, “neonatal or infant
mortality”, and “developing country” (see appendix for detailed search terms). CHERG
investigators also identified additional datasets that were not retrieved in our search. We
excluded datasets for the following reasons: greater than 25% missing data for birthweight
or gestational age, or loss to follow-up; measured weight only after the first week of life; did
not have systematic follow-up of vital status in the first month of life; determined gestational
age in months or by fundal height; or when we deemed gestational age determination
inaccurate or poorly linked to birthweight (appendix). We aimed to include only datasets
that were population-based, representing all deliveries arising from specific geographical or
catchment areas, whether home-based or facility-based. We excluded stillbirths from the
analyses of these cohorts. We approached principal investigators to do a set of standard
analyses themselves, or to share their data with the CHERG working group to do the
analyses. Datasets that were shared with the working group did not contain personal
identifiers and were therefore deemed exempt by the Johns Hopkins Bloomberg School of
Public Health institutional review board. Datasets analysed by the original study
investigators were covered under existing institutional review board approvals.
Exposure definitions
If more than one gestational age measurement was available we used estimates in the
following order of preference: ultrasound, best obstetric estimate (combination of
ultrasound, date of last menstrual period, and neonatal clinical exam), last menstrual period,
or clinical examination of the infant within 72 h of birth. Prematurity was defined as a
gestational age of less than 37 completed weeks. We categorised prematurity into less than
32 weeks (early preterm), 32 weeks to less than 34 weeks (moderate preterm), and 34 weeks
to less than 37 weeks (late preterm).14
Weight was analysed if measured within 72 h. SGA was defined as birthweight below the
tenth percentile of a standard optimal reference population for a given gestational age and
sex. Appropriate-for-gestational-age (AGA) was defined as above the tenth percentile.
WHO previously recommended data in a study by Williams and colleagues (collected in
California from 1972 to 1976) as the reference.15 We chose the more recent and commonly
cited Alexander reference,16 which includes 3 134 879 nationally representative, multi-
ethnic births in the USA in 1991. Because that dataset provided data at only the tenth
percentile, we identified another dataset (Oken and colleagues17) based on US data from
1999–2000 (6 690 717 births) that provided Z scores. We created two categories of SGA
using a combination of these two reference populations:16,17 the tenth percentile of
Alexander16 to the third percentile of Oken and colleagues,17 and the lowest third percentile
of Oken and colleagues. AGA included large-for-gestational-age (LGA) infants (≥90% birth
weight for gestational age). However, in these datasets, the prevalence of LGA was very
small and their inclusion in the reference population likely had very little effect on mortality
risk.
We created four mutually exclusive exposures to capture interaction between preterm (<37
weeks) and SGA (<10%): term and appropriate-for-gestational-age (as reference), term-
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SGA, preterm and appropriate-for-gestational-age, and preterm and SGA. We defined
mortality as early neonatal (birth to 7 days), late neonatal (8–28 days), neonatal (birth to 28
days), post-neonatal (29–365 days), and infant (birth to 365 days) mortality. For late
neonatal and post-neonatal infant mortality, the denominators were infants alive at the start
of the interval of interest with vital status available through the end of the interval.
Analysis of individual datasets
The same analysis was done on each dataset. We used an algorithm developed by Alexander
and colleagues16 to exclude infants with incompatible birthweight-gestational age
combinations. Gestational ages of less than 24 weeks and more than 48 weeks were also
excluded. We calculated the prevalence of LBW, preterm, SGA, and the overlap of these
disorders for each dataset. We calculated relative risks (RRs) and risk differences (RDs) for
early, late, neonatal, post-neonatal, and infant mortality associated with preterm and SGA
categories.
RRs were adjusted for all confounders available in each dataset (including occupation of
head of household, land ownership, years of maternal and paternal education or literacy, and
maternal age and parity). We did adjusted analyses on 13 of the 20 datasets. Regression
coefficients for the primary associations of interest were attenuated at less than 10% in all
datasets except for one,32 for which the parameters were not statistically significant.
Missing exposure data
All studies had few missing gestational age data (<10%). Analyses of mortality risk by
preterm categories used all available gestational age data, irrespective of missing
birthweight (full gestational age cohort). There were two main reasons for missing
birthweight data (most of which were from home deliveries): some infants who died soon
after delivery were not weighed, and infants who were weighed were measured at different
times after delivery. For risk estimates associated with SGA, we included infants with
weights taken within 72 h of birth (weighed cohort). For four Asian and two African studies
with missing data for birthweight or that measured some weights after 72 h, we used
multiple imputation18 to impute birthweights (appendix). The imputed datasets were used to
estimate the RRs and RDs.
Pooled analysis
Because multivariate adjustment did not substantially modify estimates of associations, we
used the crude RRs and 95% CIs, and pooled data for the major UN Millennium
Development Goal regions (Asia, Africa, and Latin America). We estimated overall and
regional RRs of mortality for each exposure variable (preterm, SGA, and combinations). We
used Stata (version 11) for all statistical analyses. Random effects models used the
DerSimonian-Laird pooled RRs and 95% CIs, given between-study heterogeneity.19
Role of the funding source
The sponsor of the study had no role in study design, data collection, data analysis, data
interpretation, or writing of the report. The corresponding author had full access to most of
the datasets, had access to all summary estimates from each dataset for meta-analysis, and
had final responsibility for the decision to submit for publication.
Results
We included 20 datasets with 2 015 019 livebirths from sub-Saharan Africa, Latin America,
and south and southeast Asia, with gestational age available for 2 008 675 babies and both
gestational age and birthweight available for 1 996 763 babies (table and appendix).4,20-40
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Study dates ranged from 1982 through to 2010. The Chilean national birth registry35
provided much of these data. The prevalence of preterm birth (<37 weeks) in the study
datasets ranged from 2·7% to 28%, with varying methods of gestational age determination
(see appendix for specific study methods). The proportions of preterm births before 32
weeks of gestation ranged from 0% to 4% (appendix). Comparison of preterm prevalence by
method of assessment was not possible because few studies used more than one method. The
prevalence of SGA was generally higher than that of preterm births, ranging from 7% in the
Chile national registry to 62% in a community-based trial in south India (appendix). The
proportion of LBW infants who were SGA or preterm varied by region (figure 1). In the
Asian cohorts, 83% of LBW infants were SGA and 33% were preterm (67% of LBW were
term and SGA). In the African cohorts, 79% of LBW infants were SGA and 38% were
preterm (62% of LBW were term and SGA). In the Latin American cohorts, 53% of LBW
infants were SGA and 71% were preterm (29% of LBW were term and SGA). South Asia
had the highest prevalence of preterm births and number of LBW and SGA infants. A
substantial proportion of SGA infants did not have LBW in Asia (54%), Africa (65%), and
Latin America (59%). The proportion of children who were both SGA and preterm was
small in these datasets (4% in Asia, 1% in Africa, and 2% in Latin America). In Africa and
Asia, term infants were more often SGA than were preterm infants, but the opposite was true
in Latin America (figure 1).
Neonatal mortality rates and relative risks increased with decreasing gestational age across
studies and regions (figure 2). Although the highest relative risks (RRs) were seen in Latin
America (mainly due to the very low mortality in the reference group), the risk differences
were similar across regions. The overall pooled RRs across all regions were 6.82 (3·56–
13·07) for neonatal mortality and 2·50 (1·48-4·22) for post-neonatal mortality. The overall
pooled RRs across all regions for late preterm (34 weeks to <37 weeks), when most preterm
births occur, were 3·05 (2·02–4·60; figure 2 and appendix). The RDs per 1000 livebirths for
late preterm ranged from nine (95% CI 0–18) in Africa to 18 (9–28) in Asia, with an overall
RD per 1000 livebirths of 13 (9–18; appendix). The overall pooled RRs for early preterm
(<32 weeks) were 28·82 (15·51-53·56; figure 2 and appendix), although the RDs per 1000
livebirths ranged from 196 (95–297) in Asia to 350 (189–511) in Latin America, with an
overall RD of 245 per 1000 livebirths (192–297; appendix). Early and late neonatal and
post-neonatal infant mortality followed similar patterns, but the RRs were more attenuated
the longer the follow-up period extended (appendix), except for early preterm in Latin
America, when mortality risk decreased substantially across the early-post-neonatal to late-
post-neonatal periods. However, a statistically significantly increased mortality risk
persisted into the post-neonatal infant period in all regions for preterm compared to term.
Imputation of missing birthweights did not alter the prevalence of SGA, which was already
high, although it did increase the risk of mortality associated with SGA (figure 3 and
appendix). Neonatal mortality rates in creased with severity of SGA (figure 3). The overall
pooled RRs for SGA across all regions were 1·83 (1·34–2·50) for neonatal mortality and
1·90 (1·32–2·73) for post-neonatal mortality. The highest RR for SGA in neonates below the
third percentile was in Latin America, compared with 1·91 (1·40–2·60) in Asia, although the
CIs overlapped. The overall RR was 2·41 (1·66–3·50). Regional pooled RDs per 1000
livebirths for SGA below the third percentile ranged from 12 (10–15) in Asia to 23 (17–29)
in Latin America, with an overall RD per 1000 livebirths of 14 (9–19; appendix). The RRs
associated with SGA were of similar magnitude in the early-neonatal, late-neonatal, and
post-neonatal periods across regions (appendix). The RRs associated with SGA were overall
of smaller magnitude than preterm, and the association with increased mortality did not
attenuate beyond the neonatal period and persisted through the first year of life.
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Relative to term and AGA, the increased risk of neonatal mortality was lowest in those born
term-SGA (overall RR 2·44, 1·67–3·57) and highest in preterm-SGA infants (15·42, 9·11–
26·12). RRs were similar for Asia and Africa, but higher in Latin America (figure 4). These
higher RRs in Latin America were probably driven by the low mortality rate (2·4 per 1000)
in the reference group. Pooled RDs were similar across regions (appendix). The RRs for
term-SGA babies did not vary by timing of mortality (figure 5). For preterm-AGA and
preterm-SGA babies, RRs were highest in the early neonatal period and lowest in the post-
neonatal period, although the CIs largely overlapped (ie, no statistically significant between-
group differences; figure 5 and appendix). This pattern of attenuated risk by length of
follow-up was probably driven by prematurity and not SGA.
Discussion
We identified a large percentage of infants who were SGA but not LBW or preterm (21% in
Asia, 16% in Africa, and 4% in Latin America), although their mortality rates were lower
than preterm infants or SGA-LBW infants. Although most LBW was in term and SGA
babies in Asia and Africa, the majority of babies with LBW in Latin America were preterm.
Preterm mortality risk associations were generally higher at all gestational age categories
(late, moderate, and early preterm) than SGA (3% to <10% or <3%). However, the
attributable mortality risk for SGA infants is substantial, because many infants in LMICs are
born SGA, especially in south Asia. The predominant increased mortality risk associated
with preterm birth occurred in the first week of life, with statistically significant but
attenuated risk remaining in the late-neonatal and post-neonatal periods. Although CIs
overlapped, mortality risks associated with SGA were slightly higher in the late than early
neonatal period, with persistent risk in the post-neonatal period.
The highest neonatal and infant mortality rates were detected in the Asian and African
studies. The highest RRs for all exposures were seen in Latin America, although absolute
risk differences were more comparable across regions. This higher RR in Latin America is
due to very low mortality in the reference group in Latin America compared with Africa and
Asia. In particular, the Latin America analysis was dominated by national registry data from
Chile in which term neonatal mortality was 1·7 per 1000 livebirths. By comparison with
these data, the average term neonatal mortality was 11 per 1000 livebirths in the African
datasets and 19 per 1000 livebirths in the Asian ones. Alternately, preterm infants might be
more severely preterm and survive delivery in Latin America but have delayed mortality.
Preterm birth was associated with an increased mortality risk compared with term birth. The
proportion of infants born within 32 weeks of gestation was low but these infants had
substantially higher mortality risks than did term infants in the first week of life. Late
preterm birth comprised 50–96% of preterm births, and was associated with a smaller but
statistically significant neonatal mortality risk ranging from 2·52 in Asia to 5·58 in Latin
America (risk differences per thousand livebirths were nine in Africa, 11 in Latin America,
and 18 in Asia). Evidence-based, low-cost interventions are feasible for LMICs and could
reduce mortality related to preterm birth complications, such as antenatal corticosteroids for
preterm labour, Kangaroo mother care, and treatment of neonatal infections.41-43 Our
findings suggest that simple interventions to target the improved care of late and moderate
preterm infants could have a large effect on the reduction of mortality burden in preterm
infants. In areas with a large proportion of facility deliveries and much post-delivery care,
clinical interventions such as surfactant administration and continuous positive airway
pressure might also improve survival.
Using a common US birthweight reference population, the prevalence of SGA and term-
SGA babies was very high (higher than 50%) in many of the community-based South Asian
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cohorts.11,12 In statistical modelling to estimate national and regional prevalences of SGA,
we estimated that 42% of babies were term-SGA and that 3% of babies were preterm-SGA.2
These findings contrast with a much lower prevalence of SGA in Africa, despite the high
prevalence of risk factors such as malaria and HIV infection in pregnancy. SGA neonates
had roughly double the mortality risk of appropriate-for-gestational-age infants, with slightly
higher risk in those with more severe SGA. A large proportion of SGA infants weighed
2500 g or more, although their mortality risk was similar to that of term-AGA babies. The
very high rates of SGA in South Asia might be explained by higher rates of adolescent
pregnancy, chronic maternal malnutrition, low pre-pregnancy body-mass index, low weight
gain in pregnancy, and low maternal height.44-46
The mortality risk associated with being preterm-SGA was substantially higher than for
either alone. An estimated 2·8 million infants are born both preterm and SGA in LMICs
annually2 and these infants are at a 10–40 times increased risk of dying in the first month of
life compared with term and appropriate-for-gestational-age infants. These children are key
targets for public health interventions.
A strength of this analysis was the large number of representative livebirths analysed from a
wide range of studies and geographical regions, producing internal validity and reduced
variance of estimates. We adjusted for several covariates but noted that they did not alter the
risk estimates. Although the cohort sizes varied substantially, with the Chilean national
registry data dominating in absolute numbers, the use of random effects models to do meta-
analyses downweights the effect of such large datasets. Although it constitutes 92% of the
data, its contribution to the Latin American mortality risk estimate is about 50% and its
contribution to the global estimate is 9·7%. While Chile is proably a good representation of a
middle-income country in Latin America, it does not represent other low-income countries
in the region. The earliest Brazilian cohort30 might be more representative of such countries
because it was done in a low-income setting.
We re-analysed individual data to estimate SGA prevalence and risk, applying a common
SGA reference population. This reduced the variation associated with the use of different
SGA reference populations commonly seen across studies. Although the use of a common
reference population is a controversial issue, with arguments made about whether it is
appropriate to apply one standard to all populations, we selected one reference population to
be able to better compare our analyses across populations. Our use of a birthweight rather
than fetal growth standard might have systematically under-represented SGA in preterm
infants because preterm infants might have more pathological IUGR than fetuses that remain
in the womb for longer. The Intergrowth Study is collecting data for common fetal growth
reference using healthy populations from many countries. The use of this standard will help
resolve this limitation in the future.
The large sample size allowed us to stratify preterm and SGA into severity categories and to
pool mortality risk associated with each category by re-analysing primary data. Available
covariates varied by study and residual con founding could have occurred. However, these
findings might not be generalisable to countries or regions as a whole because they are
derived from cohorts or randomised trials in which the geographical areas might have been
selected for specific risk characteristics as evidenced by the range of preterm prevalence
across studies (table). However, the use of meta-analyses with random effects of 20 cohorts
probably reduced the bias and increased the precision of regional and global risk estimates.
Although the prevalence of preterm and SGA births seemed quite variable across these
datasets, the mortality differences associated with these characteristics were stable within
regions. Hence these estimates are likely to be valid for use in attributable risk calculations
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if representative estimates of preterm and SGA prevalence are used and residual
confounding was minimal.
A limitation of our community-based datasets was the exclusion of early deaths in infants
who were not weighed. We used multiple imputation to address the potential effect on
mortality associations. Nevertheless, we might have underestimated the mortality risks
associated with SGA given that we were missing some covariate data with which to impute
birthweight. Another limitation is the variability and accuracy of gestational age
measurement between datasets. Nine studies included ultrasound dating, whereas the
remainder relied on maternal recall of their last menstrual period or clinical exam. We used
the best gestational age determination, excluding datapoints with improbable gestational age
and birthweight combinations and datasets with poor gestational age measures. Gestational
age categories might have been subject to some misclassification although these were
probably minimised by the active, frequent pregnancy surveillance in many studies.
Stillbirths were excluded from these analyses, but it is possible that there was
misclassification of stillbirths and livebirths, especially in home deliveries that relied on
maternal report, but the direction of this misclassification is unclear. Although assessment of
cause of death by adverse pregnancy outcome is of interest, very few studies had cause of
death, and most population-based studies that did, had cause assigned by physician via
verbal autopsy. Assessing causes of death associated with SGA or preterm in these contexts
would be a valuable future contribution to the design of appropriate mortality reduction
interventions.
Many babies are born SGA in LMICs, especially in south Asia and sub-Saharan Africa, and
such babies have increased risk of mortality and poor growth.47 Preterm birth affects a
smaller number of neonates but is associated with a higher mortality risk and seems to be a
greater contributor to attributable risk in Latin America than in Asia. In both these regions,
these risks extend beyond the neonatal period. Although few effective interventions to
prevent preterm exist,48 several interventions exist to improve preterm survival. Inter
ventions shown to reduce SGA have focused mainly on increasing calories and protein
during pregnancy, and more recently (during the past decade) maternal micro nutrient
supplementation.48 As measurement of gestational age improves in LMICs, targeting
interventions and tracking outcomes that reduce the incidence and improve the survival of
babies born preterm and SGA rather than with a LBW might more clearly guide progress
towards the reduction of child mortality.
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Figure 1. The relation between birthweight and gestational age in Asia (A), Africa (B), and Latin
America (C)
For Asian cohorts (A), percentages are for 78 048 infants. For African cohorts (B),
percentages are for 38 948 infants. For Latin American cohorts (C), percentages are for 1
910 734 infants.
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Figure 2. Relative risk of neonatal mortality associated with gestational age
Error bars are 95% CI.
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Figure 3. Relative risk of neonatal mortality associated with small for gestational age
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Figure 4. Relative risk of neonatal mortality associated with preterm and size for gestational age
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Figure 5. Relative risk of early-neonatal, late-neonatal, and post-neonatal infant mortality
associated with preterm and size for gestational age
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Table
Study characteristics of 20 included datasets




















































12 693/12 693* 38 · · 6 months 33% 14% 62% 63%
Nepal
(1999)22




















1106 1106/1052 25 · · 1 month 22% 7% 53% 53%
Nepal
(2004)29










23 650/22 723* 32 · · 6 months 30% 18% 52% 10%
Pakistan
(2003)39








1548 1464/1434 18 · · 1 month 19% 28% 28% 100%
Philippines
(1983)20






3080 3050/2785 14 36 2 years 11% 18% 25% 34%
Thailand
(2001)24
Urban Bangkok Prospective follow-up
of birth cohort
Longitudinal birth
cohort of all births in
four districts











1311/1212* 21 67 1 year 17% 16% 35% 77%
Burkina Faso
(2006)36






1316 1261/1067 20 · · 1 month 16% 18% 29% 84%
South Africa
(2004)34








8113 8113/8098 7 · · 1 month 8% 4% 16% 100%
Tanzania
(1998)32















7752 7740/7557 28 · · 6 weeks 8% 17% 20% 97%
Tanzania
(2008)38




















1561 1553/1477 17 · · 1 month 7% 6% 10% 100%
Zimbabwe
(1997)33,40







14 110 13 960/13 914













5914 4675/4670 11 28 1 year 7% 6% 17% 100%
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1 901 611 1 89 8 250/
1 898 250
5 · · 1 month 6% 7% 7% 98%
RCT=randomised controlled trial. SGA=small for gestational age. NMR=neonatal mortality rate. IMR=infant mortality rate. LBW=low
birthweight.
*
Weights imputed for datasets that met criteria described in appendix.
†
Enrolment of newborn babies occurred up to 96 h after birth, and the study might have missed neonatal deaths that happened before enrolment.
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